Preventive screening, early intervention, key to cervical cancer patient’s positive outcome

Christine Moon Patient PhotoThanks to being diligent about preventive screening, and early intervention at The University of Kansas Cancer Center, Christine Moon is sharing a cervical cancer experience with the best possible outcome. After two abnormal pap tests, Chris, 51, was diagnosed in 2017 with early stage cervical cancer. Her gynecologic oncologist, Lori Spoozak, MD, said it was likely caused by the human papillomavirus, or HPV.

Cervical cancer is the most common HPV-associated cancer. More than 90% of cervical cancers are believed to be caused by HPV.

After having a radical hysterectomy with minimally invasive robotic assisted surgery, Chris experienced a complete recovery. Since her treatment, Dr. Spoozak follows her closely   ̶   with thorough examinations every three months and regular PET scans. Chris says it’s also not unusual for Dr. Spoozak to call her just to check in.

“Dr. Spoozak and The University of Kansas Cancer Center were amazing,” said Chris, who lives in North Kansas City, Missouri. “Dr. Spoozak is warm and compassionate and always kept me informed. I had confidence in her capabilities immediately. I knew I was going to be OK. Her follow-up care has been equally amazing. It’s obvious that she cares about her patients.”

Because of her diagnosis, Chris has become a proponent of the HPV vaccine. She shares how important the vaccine is in preventing cervical cancer at every opportunity she gets   ̶  that includes discussions with her 25-year-old daughter and her daughter’s friends.

“I talked to my daughter and her bridesmaids around the time of her wedding about the HPV vaccine,” she said. “I wanted to make sure they knew about it and had received the vaccine.”

To learn more about HPV, visit kucancercenter.org/hpv.



As with all treatments, individual patient results vary. It is important to discuss your treatment options with your healthcare provider.